Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotechnologies as President of Adaptive Therapeutics

SEATTLE, Wa., Tuesday, March 15, 2016 – Adaptive Biotechnologies, the leader in next generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces the appointment of Diego Miralles, M.D., as President of Adaptive Therapeutics. Most recently Dr. Miralles was the Global Head, Johnson & Johnson Innovation where he established the Johnson & Johnson Innovation Centers, JLABS, and Janssen Healthcare Innovation.

read more here


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Portfolio Company News / Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotechnologies as President of Adaptive Therapeutics